6 Results for "

immuno-inflammatory

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "immuno-inflammatory" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-15507
CAS No.: 6501-72-0
Purity:  99.76%
Synonyms: GIT 27
VGX-1027 is an orally active isoxazole compound that exhibits various immunomodulatory properties. VGX-1027 targets macrophages, reducing the production of the proinflammatory mediators TNF-α, IL-1β, IL-10. VGX-1027 has antidiabetogenic effects by limiting cytokine-mediated immunoinflammatory events .
loading...
    loading...
Cat. No.: HY-139553
CAS No.: 1640282-42-3
Purity:  99.99%
Synonyms: ATI-450; CDD-450
Target:  

MAPKAPK2 (MK2)

Research Areas:  

Inflammation/Immunology

Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases .
loading...
    loading...
Cat. No.: HY-N2958
CAS No.: 6054-10-0
Braylin, a coumarin, is a potent phosphodiesterase-4 (PDE4) inhibitor and is involved in anti-inflammatory and immunomodulation, which may serve as a potential target for the study of immunoinflammatory diseases .
loading...
    loading...
Cat. No.: HY-139553A
CAS No.: 1640282-44-5
Purity:  97.84%
Synonyms: (R)-ATI-450; (R)-CDD-450
Target:  

Drug Isomer

Research Areas:  

Inflammation/Immunology

(R)-Zunsemetinib is the isomer of Zunsemetinib (HY-139553), and can be used as an experimental control. Zunsemetinib (CDD-450) is an orally active and selective p38α mitogen-activated protein kinase-activated protein kinase 2 (MK2) pathway inhibitor. Zunsemetinib can be used for the research of immuno-inflammatory diseases .
loading...
    loading...
Cat. No.: HY-P5509
CAS No.: 230968-98-6
Target:  

Inhibitory Antibodies

Research Areas:  

Others

C5aR1 antagonist peptide is a biological active peptide. (This linear peptide is derived from the C-terminus of the chemokine, complement fragment 5 anaphylatoxin (C5a). This peptide functions to inhibit C5a binding and function at human and rat C5a receptors. C5a is crucial to triggering cellular immune responses and its overexpression is involved in arthritis, Alzheimer’s disease, cystic fibrosis, systemic lupus erythematosus, and other immunoinflammatory diseases.)
loading...
    loading...
Cat. No.: HY-P992540
Research Areas:  

Cancer

IBI389 is an anti-Claudin18.2 × CD3 bispecific antibody. IBI389 binds CD3 and Claudin18.2 to engage T cells, induce immune synapse formation, and redirect T cell killing of Claudin18.2-positive tumors. IBI389 increases intratumoral CD3 +/CD8 + T cells, an immuno-inflammatory phenotype, shortens tumor-T cell distance, compensatorily increases regulatory T cells, and elevates IL-2/IFN-γ; IL-4/IL-10/IL-17A/TNF-α are decreased. IBI389 can be used in gastric cancer-related research .
loading...
    loading...